Product Information

OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0810 per EA under NDC 64980060203. Its NADAC has been published 90 times since Dec 4, 2024.

FDA first approved this application on May 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 20 MG TAB

olmesartan medoxomil
$0.0810per EA

Strength

20 mg/1

NDC

64980060203

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA208659

FDA Approved

5/18/2020

TE Code

AB

On Market Since

3/30/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 90 times since Dec 4, 2024, and over the history we have for it it has risen 15.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0810 per EA
All-time high$0.0855 (Jun 11, 2025)
All-time low$0.0705 (Dec 4, 2024)
52-week high$0.0825
52-week low$0.0732
Median price$0.0796
Average price$0.0795
Largest weekly change+17.3% (Dec 18, 2024)
Weeks tracked90
Tracking sinceDec 4, 2024

Price History

1W

-0.3%

1M

-0.3%

3M

+4.0%

6M

+10.8%

1Y

-1.8%

3Y

N/A

5Y

N/A

All

+15.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.0810 per EA (NDC 64980060203), effective Aug 19, 2026.

How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has risen 15.0%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?

Since Dec 4, 2024, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Dec 4, 2024) to a high of $0.0855 (Jun 11, 2025), with a median of $0.0796 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 20 MG TAB, is $0.0780 per EA — about 4% below OLMESARTAN MEDOXOMIL 20 MG TAB.

Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?

OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 64980060203) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.